Molecular Mechanisms and New Therapeutic Approaches

Thyroid carcinomas exhibit remarkable biological heterogeneity, which is increasingly shaping modern diagnosis and treatment. Molecular markers and innovative treatment approaches are fundamentally changing our understanding of pathogenesis, prognosis, and clinical management.